|
CH535201A
(de)
|
1969-12-19 |
1973-03-31 |
Bristol Myers Co |
Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren
|
|
JPS632932A
(ja)
|
1986-06-23 |
1988-01-07 |
Teijin Ltd |
経鼻投与用粉末状組成物
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US4994467A
(en)
|
1989-05-31 |
1991-02-19 |
Zimmerman Andrew W |
Treating autism and other developmental disorders in children with NMDA receptor antagonists
|
|
DE4312016A1
(de)
|
1993-04-13 |
1994-10-20 |
Goedecke Ag |
Stabile Ketamin-Lösungen
|
|
US5543434A
(en)
|
1994-02-25 |
1996-08-06 |
Weg; Stuart L. |
Nasal administration of ketamine to manage pain
|
|
DK0814790T3
(da)
|
1995-02-24 |
2003-11-10 |
Stuart L Weg |
Indgivelse af ketamin med henblik på afgiftning
|
|
WO1997007750A1
(en)
|
1995-08-30 |
1997-03-06 |
Weg Stuart L |
Administration of ketamine to manage pain and to reduce drug dependency
|
|
FR2739294B1
(fr)
|
1995-09-29 |
1998-01-16 |
Lhd Lab Hygiene Dietetique |
Embout nasal de securite
|
|
DE19619665C2
(de)
|
1996-05-15 |
2001-03-08 |
Goedecke Ag |
Racemattrennung von Ketamin
|
|
DE19723133A1
(de)
|
1997-06-03 |
1998-12-10 |
Caideil M P Teoranta Tourmakea |
Austragvorrichtung für Medien
|
|
FR2764807B1
(fr)
|
1997-06-18 |
1999-08-20 |
Valois Sa |
Dispositif de distribution nasale d'un produit fluide ou pulverulent
|
|
CA2338457C
(en)
|
1998-07-24 |
2009-11-17 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
|
US6599883B1
(en)
|
1998-10-30 |
2003-07-29 |
Nastech Pharmaceutical Company, Inc. |
Nasal delivery of xylitol
|
|
US6176242B1
(en)
|
1999-04-30 |
2001-01-23 |
Medtronic Inc |
Method of treating manic depression by brain infusion
|
|
US6017961A
(en)
|
1999-07-08 |
2000-01-25 |
Flores; John Anthony |
Ketamine and n-butyl-p-aminobezoate in PLO
|
|
EP1103256A1
(de)
|
1999-11-26 |
2001-05-30 |
Claudius Dr. med. Böck |
Verwendung von Ketamin zur Behandlung von neuroendokriner Immundysfunktion und algogenem Psychosyndrom
|
|
US6572849B2
(en)
|
2000-09-20 |
2003-06-03 |
Lee Shahinian, Jr. |
Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
|
|
US6881731B1
(en)
|
2000-10-23 |
2005-04-19 |
Shanbrom Technologies, Llc |
Enhancers for microbiological disinfection
|
|
EP1551393A4
(en)
|
2002-07-30 |
2010-06-16 |
Peter Migaly |
COMBINATION OF THERAPY FOR DEPRESSION, PREVENTION OF SUICIDE AND VARIOUS MEDICAL AND PSYCHIATRIC DISORDERS
|
|
US7273889B2
(en)
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
|
JP2006510618A
(ja)
|
2002-11-18 |
2006-03-30 |
ヤウポン セラピューティクス，インコーポレーテッド |
ノルケタミンおよびケタミン／ノルケタミンプロドラッグの鎮痛的使用
|
|
US7687080B2
(en)
|
2002-11-25 |
2010-03-30 |
Taraxos Inc. |
Treatment of neuropathy
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
US8082173B2
(en)
*
|
2003-05-22 |
2011-12-20 |
Cecil Kost |
Drug sample fulfillment architecture
|
|
US20040265364A1
(en)
|
2003-06-25 |
2004-12-30 |
Binnur Ozturk |
Neuropathy cream
|
|
US20050095277A1
(en)
|
2003-06-25 |
2005-05-05 |
Binnur Ozturk |
Neuropathy cream
|
|
WO2005079756A2
(en)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
|
|
PL2486942T3
(pl)
|
2004-11-24 |
2019-05-31 |
Meda Pharmaceuticals Inc |
Kompozycje zawierające azelastynę oraz sposoby ich stosowania
|
|
US20060223788A1
(en)
|
2005-03-29 |
2006-10-05 |
Cathcart Clifton H |
Analgesic composition for topical use
|
|
EP2526987A3
(en)
|
2005-06-01 |
2013-04-24 |
SHL Group AB |
Device for delivering medicament
|
|
US20060276550A1
(en)
|
2005-06-03 |
2006-12-07 |
Dileep Bhagwat |
Topical compositions of ketamine and butamben and methods of their use
|
|
JP2009530385A
(ja)
*
|
2006-03-22 |
2009-08-27 |
マウント シナイ スクール オブ メディシン |
うつ病の治療のためのケタミンの鼻内投与
|
|
US20070256688A1
(en)
|
2006-04-21 |
2007-11-08 |
Aradigm Corporation |
Mechanical single dose intrapulmonary drug delivery devices
|
|
EP2029136A4
(en)
|
2006-05-22 |
2010-01-06 |
Vanda Pharmaceuticals Inc |
TREATMENT FOR DEPRESSION DISEASES
|
|
DE102007009888A1
(de)
|
2007-02-28 |
2008-09-04 |
Hermann, Holger Lars, Dr. |
Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
|
|
EP2139848A1
(en)
|
2007-04-26 |
2010-01-06 |
Auspex Pharmaceuticals, Inc. |
Deuterium labelled ketamine
|
|
WO2008151179A2
(en)
*
|
2007-06-04 |
2008-12-11 |
Auspex Pharmaceuticals, Inc. |
Substituted phenethylamines
|
|
WO2009131794A1
(en)
|
2008-03-27 |
2009-10-29 |
University Of Kentucky Research Foundation |
Opioid-ketamine and norketamine codrug combinations for pain management
|
|
EP2303308A4
(en)
|
2008-05-13 |
2012-11-07 |
Clarassance Inc |
HUMAN RECOMBINANT PROTEIN CC10 AND COMPOSITIONS CONTAINING IT FOR THE TREATMENT OF NASAL RHINITIS
|
|
US20110038807A1
(en)
|
2009-08-14 |
2011-02-17 |
Demitri Papolos |
Compositions and methods for treating bipolar disorder
|
|
US20120225949A1
(en)
|
2009-08-14 |
2012-09-06 |
Demitri Papalos |
Compositions and methods for treating bipolar disorder
|
|
AU2011267474B2
(en)
|
2010-06-15 |
2016-05-26 |
Grünenthal GmbH |
Pharmaceutical combination for the treatment of pain
|
|
WO2013003669A2
(en)
|
2011-06-30 |
2013-01-03 |
University Of South Florida |
Compositions, methods of use, and methods of treatment
|
|
JP6296985B2
(ja)
|
2011-10-14 |
2018-03-20 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
うつ病及び神経障害性疼痛の治療における（２ｒ，６ｒ）−ヒドロキシノルケタミン、（ｓ）−デヒドロノルケタミン及び他の（ｒ，ｓ）−ケタミンの立体異性デヒドロ及びヒドロキシル化代謝生成物の使用
|
|
CN104053785A
(zh)
|
2011-11-14 |
2014-09-17 |
综合医院公司 |
为患有抑郁症的受试者选择治疗方案的测定法和方法
|
|
US20130209585A1
(en)
|
2012-02-13 |
2013-08-15 |
Stanley Kim |
Topical NMDA Antagonist Formulations for the Treatment of Peripheral Neuropathy
|
|
WO2013138322A1
(en)
*
|
2012-03-12 |
2013-09-19 |
Janssen Pharmaceutica Nv |
Esketamine for the treatment of treatment-refractory or treatment-resistant depression
|
|
AU2016203771A1
(en)
|
2012-03-13 |
2016-06-23 |
Janssen Pharmaceutica Nv |
Esketamine for the treatment of treatment-refractory or treatment-resistant depression
|
|
JP2015512418A
(ja)
|
2012-03-30 |
2015-04-27 |
ザ ジェネラル ホスピタル コーポレイション |
うつ病の治療におけるスコポラミンおよびケタミンを含む組成物
|
|
US20140079740A1
(en)
|
2012-08-02 |
2014-03-20 |
ClinPharm Support GmbH |
Oral transmucosal adminstration forms of s-ketamine
|
|
MX2015002378A
(es)
|
2012-08-23 |
2015-09-25 |
Stuart L Weg |
Composicion ansiolitica, formulacion y metodo de uso.
|
|
FR2994844B1
(fr)
|
2012-08-31 |
2015-01-02 |
Assist Publ Hopitaux De Paris |
Formulation gelifiante a base de ketamine
|
|
NZ619257A
(en)
|
2012-10-08 |
2015-07-31 |
Auckland Uniservices Ltd |
Ketamine derivatives
|
|
ES2484068B1
(es)
|
2013-02-08 |
2015-04-16 |
Ana MÍNGUEZ MARTÍ |
Una composición farmacéutica que contiene ketamina y amitriptilina
|
|
US20140274981A1
(en)
|
2013-03-15 |
2014-09-18 |
Janssen Pharmaceutica Nv |
Pharmaceutical composition of s-ketamine hydrochloride
|
|
KR20220044380A
(ko)
|
2013-04-12 |
2022-04-07 |
이칸 스쿨 오브 메디슨 엣 마운트 시나이 |
외상후 스트레스 장애의 치료 방법
|
|
US9913803B2
(en)
|
2013-08-26 |
2018-03-13 |
Amorsa Therapeutics, Inc. |
Single-layer oral dose of neuro-attenuating ketamine
|
|
DK3043785T3
(da)
|
2013-09-13 |
2021-11-15 |
Univ Chiba Nat Univ Corp |
Anvendelse af r-ketamin og salt deraf som lægemidler
|
|
CN103705909A
(zh)
|
2013-12-16 |
2014-04-09 |
陈镜伊 |
一种无痛人流用药
|
|
WO2015101693A1
(es)
|
2013-12-31 |
2015-07-09 |
Servicio Andaluz De Salud |
Composiciones y preparaciones combinadas para el tratamiento de las algias orofaríngeas
|
|
CA2936809A1
(en)
|
2014-01-14 |
2015-07-23 |
Children's Hospital Medical Center |
Compositions comprising ketamine for treating an autism spectrum disorder
|
|
EP3272338B1
(en)
|
2014-04-17 |
2020-09-09 |
Develco Pharma Schweiz AG |
Oral dosage form of ketamine
|
|
PE20211759A1
(es)
|
2014-05-04 |
2021-09-07 |
Firmenich & Cie |
Formulacion edulcorante con naringenina
|
|
FR3023188B1
(fr)
|
2014-07-04 |
2016-08-19 |
Aptar France Sas |
Dispositif de distribution de produit fluide.
|
|
US10098854B2
(en)
|
2014-08-13 |
2018-10-16 |
Janssen Pharmaceutica Nv |
Method for the treatment of depression
|
|
EP3193853A1
(en)
|
2014-09-15 |
2017-07-26 |
Janssen Pharmaceutica NV |
VAL66MET (SNP rs6265) GENOTYPE SPECIFIC DOSING REGIMENS AND METHODS FOR THE TREATMENT OF DEPRESSION
|
|
WO2016109427A1
(en)
|
2014-12-31 |
2016-07-07 |
Icahn School Of Medicine At Mount Sinai |
Method of maintaining the anti-depressant effect of ketamine with lithium
|
|
WO2016172672A1
(en)
|
2015-04-24 |
2016-10-27 |
Icahn School Of Medicine At Mount Sinai |
Method for treating suicidal ideation
|
|
CN104798728A
(zh)
|
2015-05-08 |
2015-07-29 |
南京中医药大学 |
产后抑郁动物模型的建立方法及其应用
|
|
US20160332962A1
(en)
|
2015-05-13 |
2016-11-17 |
Janssen Pharmaceutica Nv |
(s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
|
|
US20160338977A1
(en)
*
|
2015-05-20 |
2016-11-24 |
Janssen Pharmaceutica Nv |
Methods and kits for treating depression
|
|
CN107847469A
(zh)
|
2015-06-27 |
2018-03-27 |
美国神农制药责任有限公司 |
氯胺酮透皮递送系统
|
|
US20180296478A1
(en)
|
2016-02-12 |
2018-10-18 |
Synergistic Therapeutics, Llc |
Sublingual antidepressant and antianxiety tablet
|
|
US20180042936A1
(en)
|
2016-03-18 |
2018-02-15 |
Genomind, Inc. |
Maintenance therapy using tianeptine
|
|
SG11202005896WA
(en)
*
|
2017-12-22 |
2020-07-29 |
Janssen Pharmaceuticals Inc |
Esketamine for the treatment of depression
|
|
EP3934632A4
(en)
*
|
2019-03-05 |
2022-11-23 |
Janssen Pharmaceuticals, Inc. |
Esketamine for the treatment of depression
|